Protein kinase C β inhibition ameliorates experimental mesangial proliferative glomerulonephritis

Nephrology

Volumn 16, Issue 7, 2011, Pages 649-655

  Tokuyama, Hirobumi ^a   Kim, Sandra ^a   Zhang, Yuan ^a   Langham, Robyn G ^a   Cox, Alison J ^a   Gow, Renae M ^a   Kelly, Darren J ^a   Gilbert, Richard E ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

IgA nephropathy; mesangial proliferative glomerulonephritis; platelet derived growth factor; protein kinase C; ruboxistaurin

Indexed keywords

COLLAGEN; PROTEIN KINASE C BETA; RUBOXISTAURIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; ENZYME INHIBITION; MALE; NONHUMAN; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS; PROTEINURIA; RAT; TREATMENT OUTCOME;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, THY-1; CELL LINE; CELL PROLIFERATION; COLLAGEN; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR MATRIX; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; IMMUNOGLOBULIN G; INDOLES; MALE; MALEIMIDES; MESANGIAL CELLS; PLATELET-DERIVED GROWTH FACTOR; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; PROTEINURIA; RATS; RATS, WISTAR;

EID: 80052086616     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2011.01475.x     Document Type: Article

References (27)

1. Levy M, Berger J,. Worldwide perspective of IgA nephropathy. Am. J. Kidney Dis. 1988; 12: 340-47.
2. Floege J, Eitner F,. Immune modulating therapy for IgA nephropathy: Rationale and evidence. Semin. Nephrol. 2008; 28: 38-47.
3. Gesualdo L, Di Paolo S, Milani S, et al,. Expression of platelet-derived growth factor receptors in normal and diseased human kidney. An immunohistochemistry and in situ hybridization study. J. Clin. Invest. 1994; 94: 50-58.
4. Matsuda M, Shikata K, Makino H, et al,. Gene expression of PDGF and PDGF receptor in various forms of glomerulonephritis. Am. J. Nephrol. 1997; 17: 25-31. (Pubitemid 27062801)
5. Iida H, Seifert R, Alpers CE, et al,. Platelet-derived growth factor (PDGF) and PDGF receptor are induced in mesangial proliferative nephritis in the rat. Proc. Natl Acad. Sci. USA 1991; 88: 6560-64. (Pubitemid 21914987)
6. Johnson RJ, Raines EW, Floege J, et al,. Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor. J. Exp. Med. 1992; 175: 1413-16.
7. Floege J, Ostendorf T, Janssen U, et al,. Novel approach to specific growth factor inhibition in vivo-Antagonism of platelet-derived growth factor in glomerulonephritis by aptamers. Am. J. Pathol. 1999; 154: 169-79. (Pubitemid 29031624)
8. Gilbert RE, Kelly DJ, McKay T, et al,. PDGF signal transduction inhibition ameliorates experimental mesangial proliferative glomerulonephritis. Kidney Int. 2001; 59: 1324-32. (Pubitemid 32281220)
9. Ganz MB, Saksa B, Saxena R, Hawkins K, Sedor JR,. Pdgf and Il-1 induce and activate specific protein kinase C isoforms in mesangial cells. Am. J. Physiol. Ren. Fluid Electrolyte Physiol. 1996; 40: F108-113.
10. Ganz MB, Abu-Nader R, Saxena R, Grond J,. Protein kinase C beta(Ii) isoform is up-regulated in human proliferative glomerulonephritis. Exp. Nephrol. 1997; 5: 225-32. (Pubitemid 27232361)
11. The PKC-DMES Study Group. Effect of ruboxistaurin in patients with diabetic macular edema: Thirty-month results of the randomized PKC-DMES clinical trial. Arch. Ophthalmol. 2007; 125: 318-24.
12. Gilbert RE, Kim SA, Tuttle KR, et al,. The effect of ruboxistaurin on nephropathy in type 2 diabetes. Diabetes Care 2005; 28: 2686-90. (Pubitemid 43951160)
13. Kelly DJ, Edgley AJ, Zhang Y, et al,. Protein kinase C-beta inhibition attenuates the progression of nephropathy in non-diabetic kidney disease. Nephrol. Dial. Transplant. 2009; 24: 1782-90.
14. Nikolic-Paterson DJ, Jun Z, Tesch GH, Lan HY, Foti R, Atkins RC,. De novo CD44 expression by proliferating mesangial cells in rat anti- Thy-1 nephritis. J. Am. Soc. Nephrol. 1996; 7: 1006-14.
15. Iwata J, Nishikaze O,. New micro-turbidimetric method for determination of protein in cerebrospinal fluid and urine. Clin. Chem. 1979; 25: 1317-19. (Pubitemid 9253251)
16. Advani A, Kelly DJ, Advani SL, et al,. Role of VEGF in maintaining renal structure and function under normotensive and hypertensive conditions. Proc. Natl Acad. Sci. USA 2007; 104: 14448-53. (Pubitemid 350003281)
17. Lehr HA, Mankoff DA, Corwin D, Santeusanio G, Gown AM,. Application of photoshop-based image analysis to quantification of hormone receptor expression in breast cancer. J. Histochem. Cytochem. 1997; 45: 1559-65. (Pubitemid 27465476)
18. Lehr HA, van der Loos CM, Teeling P, Gown AM,. Complete chromogen separation and analysis in double immunohistochemical stains using Photoshop-based image analysis. J. Histochem. Cytochem. 1999; 47: 119-26.
19. Kakizaki Y, Kraft N, Atkins RC,. Differential control of mesangial cell proliferation by interferon-gamma. Clin. Exp. Immunol. 1991; 85: 157-63.
20. Lin WW, Chen BC,. Distinct PKC isoforms mediate the activation of cPLA2 and adenylyl cyclase by phorbol ester in RAW264.7 macrophages. Br. J. Pharmacol. 1998; 125: 1601-9. (Pubitemid 28548574)
21. Newton AC,. Protein kinase C: Structure, function, and regulation. J. Biol. Chem. 1995; 270: 28495-8.
22. Goekjian PG, Jirousek MR,. Protein kinase C in the treatment of disease: Signal transduction pathways, inhibitors, and agents in development. Curr. Med. Chem. 1999; 6: 877-903. (Pubitemid 29422200)
23. Fujita T, Asai T, Andrassy M, et al,. PKCbeta regulates ischemia/reperfusion injury in the lung. J. Clin. Invest. 2004; 113: 1615-23. (Pubitemid 39071685)
24. Feng X, Zhang J, Barak LS, Meyer T, Caron MG, Hannun YA,. Visualization of dynamic trafficking of a protein kinase C betaII/green fluorescent protein conjugate reveals differences in G protein-coupled receptor activation and desensitization. J. Biol. Chem. 1998; 273: 10755-62. (Pubitemid 28227692)
25. Andrassy M, Belov D, Harja E, et al,. Central role of PKCbeta in neointimal expansion triggered by acute arterial injury. Circ. Res. 2005; 96: 476-83. (Pubitemid 40354542)
26. Boyle AJ, Kelly DJ, Zhang Y, et al,. Inhibition of protein kinase C reduces left ventricular fibrosis and dysfunction following myocardial infarction. J. Mol. Cell Cardiol. 2005; 39: 213-21. (Pubitemid 40995010)
27. Robin P, Boulven I, Bôle-Feysot C, Tanfin Z, Leiber D,. Contribution of PKC-dependent and -independent processes in temporal ERK regulation by ET-1, PDGF, and EGF in rat myometrial cells. Am. J. Physiol. Cell Physiol. 2004; 286: C798-806. (Pubitemid 38543808)